Browse by author
Lookup NU author(s): Melanie Gomes, Dr Mario Abinun, Professor Sophie Hambleton, Professor Andrew Cant, Dr Terence Flood
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Autoimmune lymphoproliferative syndrome (ALPS) is mainly caused by defects in the CD95 pathway Raised CD3+TCR alpha beta+CD4-CD8- double negative T cells and impaired T cell apoptosis are hallmarks of the disease In contrast, the B cell compartment has been less well studied We found an altered distribution of B cell subsets with raised transitional B cells and reduced marginal zone B cells, switched memory B cells and plasma blasts in most of 22 analyzed ALPS patients Moreover, 5 out of 66 ALPS patients presented with low IgG and susceptibility to infection revealing a significant overlap between ALPS and common variable immunodeficiency (CVID) In patients presenting with lymphoproliferation, cytopenia, hypogammaglobulinemia and impaired B cell differentiation, serum biomarkers were helpful in addition to apoptosis tests for the identification of ALPS patients Our observations may indicate a role for apoptosis defects in some diseases currently classified as CVID (C) 2010 Elsevier Inc All rights reserved
Author(s): Rensing-Ehl A, Warnatz K, Fuchs S, Schlesier M, Salzer U, Draeger R, Bondzio I, Joos Y, Janda A, Gomes M, Abinun M, Hambleton S, Cant A, Shackley F, Flood T, Waruiru C, Beutel K, Siepermann K, Dueckers G, Niehues T, Wiesel T, Schuster V, Seidel MG, Minkov M, Sirkia K, Kopp MV, Korhonen M, Schwarz K, Ehl S, Speckmann C
Publication type: Article
Publication status: Published
Journal: Clinical Immunology
Year: 2010
Volume: 137
Issue: 3
Pages: 357-365
Print publication date: 15/09/2010
ISSN (print): 1521-6616
ISSN (electronic): 1521-7035
Publisher: Academic Press
URL: http://dx.doi.org/10.1016/j.clim.2010.08.008
DOI: 10.1016/j.clim.2010.08.008
Altmetrics provided by Altmetric
